X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB GSK PHARMA UNICHEM LAB/
GSK PHARMA
 
P/E (TTM) x -30.2 60.5 - View Chart
P/BV x 0.7 11.3 5.8% View Chart
Dividend Yield % 2.6 2.5 101.3%  

Financials

 UNICHEM LAB   GSK PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
GSK PHARMA
Mar-18
UNICHEM LAB/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs3822,760 13.8%   
Low Rs2342,040 11.5%   
Sales per share (Unadj.) Rs116.3339.0 34.3%  
Earnings per share (Unadj.) Rs-18.941.4 -45.7%  
Cash flow per share (Unadj.) Rs-11.745.9 -25.6%  
Dividends per share (Unadj.) Rs5.0035.00 14.3%  
Dividend yield (eoy) %1.61.5 111.3%  
Book value per share (Unadj.) Rs381.0242.9 156.9%  
Shares outstanding (eoy) m70.3484.70 83.0%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.67.1 37.4%   
Avg P/E ratio x-16.357.9 -28.1%  
P/CF ratio (eoy) x-26.252.3 -50.2%  
Price / Book Value ratio x0.89.9 8.2%  
Dividend payout %-26.484.5 -31.3%   
Avg Mkt Cap Rs m21,668203,280 10.7%   
No. of employees `0002.3NA-   
Total wages/salary Rs m2,0065,234 38.3%   
Avg. sales/employee Rs Th3,587.8NM-  
Avg. wages/employee Rs Th880.0NM-  
Avg. net profit/employee Rs Th-583.7NM-  
INCOME DATA
Net Sales Rs m8,18028,715 28.5%  
Other income Rs m610545 111.9%   
Total revenues Rs m8,79029,260 30.0%   
Gross profit Rs m-1,3205,059 -26.1%  
Depreciation Rs m505380 132.9%   
Interest Rs m802 4,005.0%   
Profit before tax Rs m-1,2955,222 -24.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0178 0.0%   
Tax Rs m331,892 1.8%   
Profit after tax Rs m-1,3313,508 -37.9%  
Gross profit margin %-16.117.6 -91.6%  
Effective tax rate %-2.636.2 -7.1%   
Net profit margin %-16.312.2 -133.2%  
BALANCE SHEET DATA
Current assets Rs m23,31821,815 106.9%   
Current liabilities Rs m4,63515,999 29.0%   
Net working cap to sales %228.420.3 1,127.6%  
Current ratio x5.01.4 368.9%  
Inventory Days Days12264 191.5%  
Debtors Days Days12119 650.0%  
Net fixed assets Rs m8,16312,475 65.4%   
Share capital Rs m141847 16.6%   
"Free" reserves Rs m26,66019,726 135.2%   
Net worth Rs m26,80120,573 130.3%   
Long term debt Rs m36 55.0%   
Total assets Rs m31,89039,475 80.8%  
Interest coverage x-15.22,612.0 -0.6%   
Debt to equity ratio x00 42.2%  
Sales to assets ratio x0.30.7 35.3%   
Return on assets %-3.98.9 -44.1%  
Return on equity %-5.017.1 -29.1%  
Return on capital %-4.526.2 -17.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4,356564 772.4%   
Fx outflow Rs m07,429 0.0%   
Net fx Rs m4,356-6,865 -63.5%   
CASH FLOW
From Operations Rs m-1,1234,728 -23.8%  
From Investments Rs m16,487-1,042 -1,582.4%  
From Financial Activity Rs m-8,811-3,066 287.3%  
Net Cashflow Rs m6,552620 1,057.3%  

Share Holding

Indian Promoters % 50.1 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 15.1 10.2 148.0%  
FIIs % 3.0 23.8 12.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 15.4 205.8%  
Shareholders   20,176 102,036 19.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   PLETHICO PHARMA  DIVIS LABORATORIES  FULFORD INDIA  ALKEM LABORATORIES  AJANTA PHARMA  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades 370 Points Up; Hero MotoCorp & Tata Motors Gain Over 5%(12:30 pm)

Stock markets in India are presently trading higher following the outcome of assembly polls announced on Tuesday.

Related Views on News

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 22.7% (Quarterly Result Update)

Oct 23, 2018 | Updated on Oct 23, 2018

For the quarter ended September 2018, GSK PHARMA has posted a net profit of Rs 1 bn (down 22.7% YoY). Sales on the other hand came in at Rs 8 bn (down 2.4% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Dec 12, 2018 02:41 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - ORCHID PHARMA LTD COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS